Mamantia, Rejane .
HRN: 23-58-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/10/2023
09/16/2023
IV
0.11mg/ml (1ml)
Q8hrs
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes